Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

G9080 Onc diagnosis prostate with rise psa

G Codes

Also known as: prostate cancer PSA recurrence, biochemical recurrence prostate

Performance measure documenting prostate cancer with rising prostate-specific antigen (PSA) indicating biochemical recurrence.

In Plain Language

prostate cancer marker is rising; PSA recurrence of prostate cancer

Clinical Context

Quality measure for prostate cancer surveillance documenting biochemical recurrence indicated by PSA rise.

RVU Information

CPT G9080 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.

Billing & Documentation

G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.

How This Code Compares

This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.

Specialties

UrologyMedical Oncology

Frequently Asked Questions

What is CPT code G9080?

CPT G9080 (Onc diagnosis prostate with rise psa) is a G Codes code. Performance measure documenting prostate cancer with rising prostate-specific antigen (PSA) indicating biochemical recurrence.

Who uses CPT code G9080?

CPT G9080 is used by Urology, Medical Oncology. Quality measure for prostate cancer surveillance documenting biochemical recurrence indicated by PSA rise.

When is CPT G9080 used?

Quality measure for prostate cancer surveillance documenting biochemical recurrence indicated by PSA rise.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against national data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.